Results 91 to 100 of about 4,220 (134)

Role of β-Arrestin2 Signaling in Neuropharmacological Effects of Psychedelic Drugs. [PDF]

ACS Chem Neurosci
Ippolito A, Tiranti A, Hurley S, Gilmour G, Churchill G, Sharp T.   +5 more
europepmc   +1 more source

Risks from self-medicating with psychedelic drugs. [PDF]

World Psychiatry
Black JC.
europepmc   +1 more source

Adverse Health Outcomes of Psilocybin, LSD, MDMA, Ibogaine, and 5-MeO-DMT.

JAMA Netw Open
Simonsson O, Bradley M, Black JC, Rockhill KM, Monte AA, Hendricks PS.   +5 more
europepmc   +1 more source

Neuroplastic white matter changes in patients with major depression following lysergic acid diethylamide treatment. [PDF]

Cell Rep Med
Avram M, Menegaux A, Müller F, Zaczek H, Korda A, Rogg H, Becker AM, Ley L, Liechti ME, Borgwardt S.   +9 more
europepmc   +1 more source

The effects of psychedelics on attention deficit and hyperactivity disorder - a systematic review. [PDF]

Acta Neuropsychiatr
Raikkerus H, Bujour A, Kennedy M, Tiihonen J.   +3 more
europepmc   +1 more source

Psychedelic exposure in pregnancy: a scoping review to inform perinatal drug safety and clinical counseling. [PDF]

Ther Adv Drug Saf
Albert OM, Arthur A.
europepmc   +1 more source

The toxicity of psychedelic LSD derivatives: 1-acetyl-LSD (ALD-52), 1-propionyl-LSD (1P-LSD), 1-butyryl-LSD (1B-LSD), 1-valeryl-LSD (1V-LSD) and 1-cyclopropylmethanoyl-LSD (1cP-LSD)-prediction of toxicological parameters relevant to clinical and forensic toxicology using multi-in silico approach. [PDF]

Arch Toxicol
Jurowski K, Krośniak A, Kobylarz D, Fijałkowska O.   +3 more
europepmc   +1 more source

Assessment of drug harm by final-year medical students and ChatGPT - a comparative analysis. [PDF]

Subst Abuse Treat Prev Policy
Näslund I, Ott M, Vucins A, Werneke U.
europepmc   +1 more source